Hospital/Health-System Pharmacy

Measles re-emergesHealth plans and providers play a critical role in maintaining U.S. vaccination rates and can help reverse the recent MMR vaccination-rate decline, a factor responsible for the recent re-emergence of measles.
Insurer and medical association launch accountable care physician resourceIn what is being called a first-of-its-kind joint effort, the Texas Medical Association and Blue Cross and Blue Shield of Texas are launching a resource initiative to assist independent physicians with providing accountable care.
High-dose flu vaccine more effective in prevention of influenza hospitalizations in elderlyHigh-dose inactivated influenza vaccinations from community pharmacists during 2012-2013 flu season were more effective than standard-dose inactivated flu shots in patients 65 years and older, and helped in the prevention of influenza-associated hospitalizations, according to a comparative effectiveness study published in The Lancet Infectious Diseases.

Advertisement

Gilead receives approval for two HIV-1 cocktail drugsFDA has approved two new HIV-1 cocktail drugs: elvitegravir (Vitekta, Gilead), an integrase inhibitor and cobicistat (Tybost, Gilead), a protease-inhibitor booster.
Buprenorphine tops list for pediatric poisoning requiring hospitalizationResearchers from the Centers for Disease Control and Prevention (CDC) and FDA undertook a study to determine the most commonly implicated active ingredients responsible for childhood poisonings that required emergency hospitalization in the hope of identifying prevention and intervention strategies. Buprenorphine and clonidine were the most common of 12 active ingredients that were found in 45.0% of these hospitalizations.
FDA approves droxidopa to treat neurogenic orthostatic hypotensionNOH is a rare, chronic, and debilitating drop in blood pressure upon standing. It is associated with Parkinson's disease, multiple system atrophy, and pure autonomic failure.

Advertisement

Another SGLT2 inhibitor for type 2 diabetes is approvedFDA has approved empagliflozin (Jardiance, Boehringer Ingelheim Pharmceuticals) as another option for adult patients with type 2 diabetes.
New adjunctive treatment for partial-onset seizuresFDA approved eslicarbazepine acetate on November 8, 2013 as an adjunctive treatment of partial-onset seizures in adults.
Appleā€™s HealthKit: What physicians need to knowTechnology giant Apple unveiled its new operating system, iOS 8, on June 2, and a new platform called HealthKit has the healthcare IT industry abuzz with its possibilities.
More veterans could seek healthcare from private practices, hospitalsPrivate physicians and hospitals could be treating more veterans in the near future, as the U.S. Department of Veterans Affairs is working to alleviate its overburdened healthcare system amid reports of mismanagement that has led to backlogged treatment.

Advertisement

Advertisement